Induction of chemokine receptor CXCR4 expression by transforming growth factor-β1 in human basal cell carcinoma cells

Journal of Dermatological Science

Volumn 72, Issue 2, 2013, Pages 123-133

  Chu, Chia Yu ^a   Sheen, Yi Shuan ^a   Cha, Shih Ting ^a,b   Hu, Yeh Fang ^a   Tan, Ching Ting ^a   Chiu, Hsien Ching ^a   Chang, Cheng Chi ^a   Chen, Min Wei ^a,b   Kuo, Min Liang ^a,b   Jee, Shiou Hwa ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Basal cell carcinoma; Chemokine; Invasion; Transforming growth factor

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CONNECTIVE TISSUE GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE 3; NEUTRALIZING ANTIBODY; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR ETS 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1; CXCR4 PROTEIN, HUMAN; ETS1 PROTEIN, HUMAN; HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; RECOMBINANT PROTEIN;

ARTICLE; BASAL CELL CARCINOMA; CARCINOMA CELL; CARCINOMA IN SITU; CELL LEVEL; CELL SURFACE; CLINICAL ARTICLE; COCULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; CTGF GENE; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING; INVASIVE CARCINOMA; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN SYNTHESIS REGULATION; RECEPTOR BINDING; SKIN FIBROBLAST; STROMA CELL; TGF BETA1 GENE; TRANSCRIPTION REGULATION; TUMOR MICROENVIRONMENT; UPREGULATION; CYTOLOGY; DOMINANT GENE; DOSE RESPONSE; FIBROBLAST; GENE EXPRESSION REGULATION; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PHOSPHORYLATION; SKIN TUMOR; TIME; TUMOR CELL LINE; TUMOR INVASION;

CARCINOMA, BASAL CELL; CELL LINE, TUMOR; COCULTURE TECHNIQUES; CONNECTIVE TISSUE GROWTH FACTOR; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, DOMINANT; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; PHOSPHORYLATION; PROTO-ONCOGENE PROTEIN C-ETS-1; RECEPTORS, CXCR4; RECOMBINANT PROTEINS; SKIN NEOPLASMS; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84885050495     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2013.06.011     Document Type: Article

References (39)

1. Wong C.S.M., Strange R.C., Lear J.T. Basal cell carcinoma. Br Med J 2003, 327(7418):794-798.
2. Lear J.T., Harvey I., de Berker D., Strange R.C., Fryer A.A. Basal cell carcinoma. J Roy Soc Med 1998, 91(11):585-588.
3. Walling H.W., Fosko S.W., Geraminejad P.A., Whitaker D.C., Arpey C.J. Aggressive basal cell carcinoma: presentation, pathogenesis, and management. Cancer Metastasis Rev 2004, 23(3-4):389-402.
4. Rippey J.J. Why classify basal cell carcinomas?. Histopathology 1998, 32(5):393-398.
5. Rubin A.I., Chen E.H., Ratner D. Basal-cell carcinoma. N Engl J Med 2005, 353(21):2262-2269.
6. Chu C.Y., Cha S.T., Chang C.C., Hsiao C.H., Tan C.T., Lu Y.C., et al. Involvement of matrix metalloproteinase-13 in stromal-cell-derived factor-1α (SDF-1α)-directed invasion of human basal cell carcinoma cells. Oncogene 2007, 26(17):2491-2501.
7. Chu C.Y., Cha S.T., Lin W.C., Lu P.H., Tan C.T., Chang C.C., et al. Stromal-cell-derived factor-1α (SDF-1α/CXCL12)-enhanced angiogenesis of human basal cell carcinoma cells involves ERK1/2-NF-κB/interleukin-6 pathway. Carcinogenesis 2009, 30(2):205-213.
8. Leask A., Holmes A., Abraham D.J. Connective tissue growth factor: a new and important player in the pathogenesis of fibrosis. Curr Rheumatol Rep 2002, 4(2):136-142.
9. Denton C.P., Abraham D.J. Transforming growth factor-beta and connective tissue growth factor: key cytokines in scleroderma pathogenesis. Curr Opin Rheumatol 2001, 13(6):505-511.
10. Chu C.Y., Chang C.C., Prakash E., Kuo M.L. Connective tissue growth factor (CTGF) and cancer progression. J Biomed Sci 2008, 15(6):675-685.
11. Furue M., Kato M., Nakamura K., Nashiro K., Kikuchi K., Okochi H., et al. Dysregulated expression of transforming growth factor beta and its type-I and type-II receptors in basal-cell carcinoma. Int J Cancer 1997, 71(4):505-509.
12. Schmid P., Itin P., Rufli T. In situ analysis of transforming growth factors-beta (TGF-beta 1, TGF-beta 2 TGF-beta 3) and TGF-beta type II receptor expression in basal cell carcinomas. Br J Dermatol 1996, 134(6):1044-1051.
13. Stamp G.W., Nasim M., Cardillo M., Sudhindra S.G., Lalani E.N., Pignatelli M. Transforming growth factor-beta distribution in basal cell carcinomas: relationship to proliferation index. Br J Dermatol 1993, 129(1):57-64.
14. Yen H.T., Chiang L.C., Wen K.H., Tsai C.C., Yu C.L., Yu H.S. The expression of cytokines by an established basal cell carcinoma cell line (BCC-1/KMC) compared with cultured normal keratinocytes. Arch Dermatol Res 1996, 288(3):157-161.
15. Jee S.H., Chiu H.C., Tsai T.F., Tsai W.L., Liao Y.H., Chu C.Y., et al. The phosphotidyl inositol 3-kinase/Akt signal pathway is involved in interleukin-6-mediated Mcl-1 upregulation and anti-apoptosis activity in basal cell carcinoma cells. J Invest Dermatol 2002, 119(5):1121-1127.
16. Ko K., Yazumi S., Yoshikawa K., Konda Y., Nakajima M., Chiba T., et al. Activation of fibroblast-derived matrix metalloproteinase-2 by colon-cancer cells in non-contact co-cultures. Int J Cancer 2000, 87(2):165-171.
17. Caruz A., Samsom M., Alonso J.M., Alcami J., Baleux F., Virelizier J.L., et al. Genomic organization and promoter characterization of human CXCR4 gene. FEBS Lett 1998, 426(2):271-278.
18. Cha S.T., Chen P.S., Johansson G., Chu C.Y., Wang M.Y., Jeng Y.M., et al. MicroRNA-519c suppresses hypoxia-inducible factor-1α expression and tumor angiogenesis. Cancer Res 2010, 70(7):2675-2685.
19. Kang Y. Pro-metastasis function of TGF-β mediated by the Smad pathway. J Cell Biochem 2006, 98(6):1380-1390.
20. Wang G., Matsuura I., He D., Liu F. Transforming growth factor-β-inducible phosphorylation of Smad3. J Biol Chem 2009, 284(15):9663-9673.
21. Maroni P., Bendinelli P., Matteucci E., Desiderio M.A. HGF induces CXCR4 and CXCL12-mediated tumor invasion through Ets1 and NF-κB. Carcinogenesis 2007, 28(2):267-279.
22. Marsh D., Dickinson S., Neill G.W., Marshall J.F., Hart I.R., Thomas G.J. αvβ6 integrin promotes the invasion of morphoeic basal cell carcinoma through stromal modulation. Cancer Res 2008, 68(9):3295-3303.
23. Chujo S., Shirasaki F., Kawara S., Inagaki Y., Kinbara T., Inaoki M., et al. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model. J Cell Physiol 2005, 203(2):447-456.
24. Kubo M., Kikuchi K., Nashiro K., Kakinuma T., Hayashi N., Nanko H., et al. Expression of fibrogenic cytokines in desmoplastic malignant melanoma. Br J Dermatol 1998, 139(2):192-197.
25. Li A.G., Lu S.L., Han G., Kulesz-Martin M., Wang X.J. Current view of the role of transforming growth factor β1 in skin carcinogenesis. J Invest Dermatol Symp Proc 2005, 10(2):110-117.
26. Han G., Lu S.L., Li A.G., He W., Corless C.L., Kulesz-Martin M., et al. Distinct mechanisms of TGF-β1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis. J Clin Invest 2005, 115(7):1714-1723.
27. Buckley C.D., Amft N., Bradfield P.F., Pilling D., Ross E., Arenzana-Seisdedos F., et al. Persistent induction of the chemokine receptor CXCR4 by TGF-β1 on synovial T cells contributes to their accumulation within the rheumatoid synovium. J Immunol 2000, 165(6):3423-3429.
28. Franitza S., Kollet O., Brill A., Vaday G.G., Petit I., Lapidot T., et al. TGF-β1 enhances SDF-1α-induced chemotaxis and homing of naïve T cells by up-regulating CXCR4 expression and downstream cytoskeletal effector molecules. Eur J Immunol 2002, 32(1):193-202.
29. Jourdan P., Abbal C., Nora N., Hori T., Uchiyama T., Vendrell J.P., et al. IL-4 induces functional cell-surface expression of CXCR4 on human T cells. J Immunol 1998, 160(9):4153-4157.
30. Sallusto F., Lenig D., Mackay C.R., Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 1998, 187(6):875-883.
31. Peled A., Petit I., Kollet O., Magid M., Ponomaryov T., Byk T., et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 1999, 283(5403):845-848.
32. Salcedo R., Wasserman K., Young H.A., Grimm M.C., Howard O.M., Anver M.R., et al. Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: in vivo neovascularization induced by stromal-derived factor-1α. Am J Pathol 1999, 154(4):1125-1135.
33. Matteucci E., Locati M., Desiderio M.A. Hepatocyte growth factor enhances CXCR4 expression favoring breast cancer cell invasiveness. Exp Cell Res 2005, 310(1):176-185.
34. Miyazono K., Suzuki H., Imamura T. Regulation of TGF-β signaling and its roles in progression of tumors. Cancer Sci 2003, 94(3):230-234.
35. Moriuchi M., Moriuchi H., Turner W., Fauci A.S. Cloning and analysis of the promoter region of CXCR4, a coreceptor for HIV-1 entry. J Immunol 1997, 159(9):4322-4329.
36. Katoh M., Katoh M. Integrative genomic analyses of CXCR4: Transcriptional regulation of CXCR4 based on TGFß, Nodal, Activin signaling and POU5F1, FOXA2, FOXC2, FOXH1, SOX17, and GFI1 transcription factors. Int J Oncol 2010, 36(2):415-420.
37. Helbig G., Christopherson K.W., Bhat-Nakshatri P., Kumar S., Kishimoto H., Miller K.D., et al. NF-κB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4. J Biol Chem 2003, 278(24):21631-21638.
38. Dittmer J. The biology of the Ets1 proto-oncogene. Mol Cancer 2003, 2:29.
39. Yordy J.S., Muise-Helmericks R.C. Signal transduction and the Ets family of transcription factors. Oncogene 2000, 19(55):6503-6513.